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Abstract
Background: An Alternating high- cholesterol dietary regimen has proven to be beneficial when compared to daily high-
cholesterol feeding. In the current study we explored whether the same strategy is applicable to a high- fat dietary regimen.
Objective: To investigate whether an alternating high- fat dietary regimen can effectively diminish insulin resistance,
hepatic and renal inflammation and renal dysfunction as compared to a continuous high- fat diet.
Design: Four groups of male ApoE*3Leiden mice (n = 15) were exposed to different diet regimens for 20 weeks as follows:
Group 1: low- fat diet (10 kcal% fat); Group 2: intermediate- fat diet (25 kcal% fat); Group 3: high- fat diet (45 kcal% fat) and
Group 4: alternating- fat diet (10 kcal% fat for 4 days and 45 kcal% fat for 3 days in a week).
Results: Compared to high fat diet feeding, the alternating and intermediate- fat diet groups had reduced body weight gain
and did not develop insulin resistance or albuminuria. In addition, in the alternating and intermediate- fat diet groups,
parameters of tissue inflammation were markedly reduced compared to high fat diet fed mice.
Conclusion: Both alternating and intermediate- fat feeding were beneficial in terms of reducing body weight gain, insulin
resistance, hepatic and renal inflammation and renal dysfunction. Thus beneficial effects of alternating feeding regimens on
cardiometabolic risk factors are not only applicable for cholesterol containing diets but can be extended to diets high in fat
content.
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Introduction
In recent decades the prevalence of obesity and overweight has
increased tremendously worldwide. This is a major health issue
because obesity and overweight are important risk factors for
cardiovascular disease (CVD), insulin resistance, and type 2
diabetes mellitus (T2DM) [1,2].
Obesity develops when an imbalance exists between calories
consumed and calories burned and is linked to increased
consumption of energy dense foods high in fats and sugars in
combination with reduced physical activity [3,4]. Strict dietary
interventions need to be implemented to reduce obesity and its
related complications. An effective dietary intervention to improve
health is a caloric restriction diet which aims to reduce caloric
intake to a level 15–40% lower than is typical. This approach was
found to reduce cardiovascular risk factors and improve insulin
sensitivity [5,6]. More recently, an alternative to the caloric
restriction diet, an alternate day fasting regimen, also has shown
promising results [7].
Despite the beneficial health effects of caloric restriction, most
individuals find it difficult to comply with such strict regimens.
Therefore, alternative forms of dietary interventions are desired
that are more easy to adapt to but have similar beneficial health
effects. Recently, we showed that alternating dietary composition
can effectively modulate metabolic and cardiovascular risk factors.
In this study, we demonstrated that feeding ApoE*3Leiden(E3L)
mice with an alternating high-cholesterol (3 days/week) and a
cholesterol-free western type diet (4 days/week) for 16 weeks,
strongly diminished hepatic, vascular and renal activation and
inflammation, and mimicked most of the beneficial effects of a
continuous cholesterol-free dietary regimen [8].
The above dietary cholesterol study provided evidence for the
concept of alternating dietary regimen as a strategy to diminish
detrimental effects of an unhealthy diet. It is unknown whether the
same principle is applicable to dietary factors other than
cholesterol. To address this question, the current study was
designed to test whether an alternating diet strategy would also be
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beneficial for fat- containing diets wherein high fat diet is
alternated with low fat diet. Previously, it has been shown that
feeding E3L male mice on a western type high- fat diet leads to
insulin resistance and inflammation in both liver and adipose tissue
[9,10]. In the current study, we investigated whether an
alternating low- fat (4 days)/high- fat (3 days) dietary regimen
was able to diminish the adverse effects caused by a continuous
high- fat diet in E3L mice.
Materials and Methods
Animals and Diets
Animal experiments were performed according to the criteria
outlined in the ‘‘Guide for the Care and Use of Laboratory
Animals’’ published by the National Institutes of Health (NIH) and
were approved by the University of Groningen, ethical committee
on animal care and experimentation (DEC no: 6141 A). Male
ApoE*3-Leiden transgenic (E3L) mice (n = 60) were obtained from
TNO-Metabolic Health Research, Gaubius Laboratory, Leiden,
The Netherlands. Mice (12–15 weeks old) were group housed (3–5
mice per cage) with a 12 h light-dark cycle and had access to water
and diet ad libitum. Prior to their respective fat diet treatments, all
animals received a lard fat diet containing 10 kcal% from fat (low-
fat diet (LFD), (D11032101, Research Diets, NJ, USA).
Study Design
A schematic representation of the study design including blood
and urine collection is depicted in Figure S1. Prior to the start of
the experimental treatment period, mice were subjected to an oral
glucose tolerance test (OGTT) at t =22 weeks. After a recovery
period of 2 weeks, animals were individually housed in metabolic
cages and 24 hour urine was collected. Animals were randomly
divided into four groups of 15 animals each and all mice in
different groups were treated similarly in terms of handling, and
stress to exposures. Technicians performing the analysis were
blinded to treatment groups. Group 1 continued on the LFD until
the end of the experiment. Group 2 received a lard fat diet
containing 25 kcal% from fat (Intermediate- fat (IFD),
(D11032102, Research Diets, NJ, USA). Group 3 received a lard
fat diet containing 45 kcal% from fat (High- fat diet (HFD),
(D11032103, Research Diets, NJ, USA). Group 4 was subjected to
an alternating diet regimen (Alternating- fat diet (AFD)) constitut-
ing of four days of LFD, followed by three days of HFD in a week.
The composition of the different diets used in this study is provided
in Table S1. The difference in dietary fat content was
compensated with carbohydrates while the other dietary compo-
nents were similar in all diets.
Body weight (individually, every 2 weeks) and food intake (at
cage level, every 8 weeks) were monitored and blood samples were
taken by orbital puncture under anesthesia after 4 hours of fasting
at t = 0 and weeks 4, 8, 12 and 16. At week 18, animals were
subjected to OGTT and monitored for glucose clearance from
blood. At weeks 10 and 19, animals were housed individually in
metabolic cages to collect 24 hour urine. After twenty weeks of the
experimental diet feeding, mice were fasted for 4 hours and
sacrificed by Isofluorane/CO2 and organs were isolated and
weighed. Adipose tissues, aortas, livers (median lobe) and kidneys
(left) were fixed and embedded in paraffin; livers (sinister and
caudate lobes) and kidneys (right) were snap frozen in liquid N2
and stored at 280uC until further use. We considered week 16 as
the end point for both body weight and plasma analysis to avoid a
possible influence of stress the mice may have experience due to
OGTT and 24 hour urine collection performed after 16 weeks.
Oral Glucose Tolerance Test
Glucose tolerance tests were performed after a 5h-fasting
period. Mice were injected with a bolus of glucose (2 g/kg body
weight, 20% glucose in water) orally and blood glucose levels were
monitored for 120 minutes using a hand-held glucose analyzer
(LifeScan, Milpitas, CA, USA) at t = 0 min, 15 min, 30 min,
60 min, and 120 min after glucose injection.
Analysis of Plasma Lipids
Total plasma cholesterol and triglyceride levels were measured
after 4 hours of fasting; using commercial kits (catalogue
No. 11489437 and 11488872, respectively; Roche Diagnostics,
Almere, The Netherlands). The plasma levels of insulin (Alpco,
Tilburg, The Netherlands) were determined by ELISA according
to the manufacturer’s instructions.
Renal and Hepatic RNA Extraction and Gene Expression
Analysis
Total RNA was extracted from thirty 5- mm thin cryo-sections
from both kidney and liver using RNeasy Mini plus Kit (Qiagen,
Westburg, Leusden, The Netherlands) according to the manufac-
turer’s instructions. Integrity of RNA was determined by Agarose
gel electrophoresis. RNA quantity (OD-260) and quality (OD-
260/OD-280) were determined using an ND-1,000 UV-Vis
spectrophotometer (NanoDrop Technologies, Rockland, DE).
Total RNA was reverse-transcribed using SuperScript III
reverse transcriptase (Invitrogen, Breda, The Netherlands) and
random hexamer primers (Promega, Leiden, The Netherlands).
To detect the expression of selected target genes Assays-On-
DemandTM gene expression primer/probe sets (ABI Systems,
Foster City, CA) were used. Endogenous PPIA (assay ID
Mm02342430_g1) and B-actin (assay Mm01205647_g1) were
used as housekeeping genes along with the following probes: CD68
(assay IDMm00839636_g1), monocyte chemotactic protein-1
(MCP-1; assay IDMm00441242_m1), VCAM-1 (assay
IDMm00449197_m1), inter-cellular adhesion molecule 1
(ICAM-1, assay IDMm00516023_m1), Endothelin-1 (assay
IDMm00438656_m1), E-selectin (assay IDMm00441278_m1),
Desmin (assay Mm01205647_g1), Neutrophil gelatinase-associat-
ed lipocalin (NGAL, assay ID Mm01324470_m1), Kidney Injury
Molecule 1 (KIM-1, assay IDMm00506686_m1), and PDGF-b
(assay Mm00440678_m1). Real-time PCR was performed in
duplicate and the obtained threshold cycle (CT) values were
averaged. Relative mRNA levels were calculated as 22DCT, in
which DCT is CT gene of interest – CT housekeeping gene.
Histology and Immunohistochemistry
For light microscopy, 5 mm epididymal fat tissue and 3 mm
renal paraffin sections were stained with Periodic acid-Schiff’s
(PAS). In short, paraffin sections were deparaffinized and re-
hydrated in distilled water. Sections were placed in 0.5% periodic
acid solution for 5 minutes. After rinsing in distilled water, sections
were incubated in Schiff’s reagent (Sigma) for 15 minutes followed
by rinsing in lukewarm water for 5 minutes. Sections were
counterstained with Mayer’s hematoxylin for 1 minute and
washed in tap water. Immunohistochemical staining for macro-
phages, E-selectin and VCAM-1 were performed on acetone-fixed
5 mm cryosections using an anti-rabbit peroxidase-based Envi-
sionH+ system (DakoCytomation, Carpinteria, CA, USA). Briefly,
sections were incubated for 60 min with 5 mg/ml rat-anti-mouse
CD68 (clone FA11, serotech, Puchheim, Germany), 10 mg/ml rat-
anti-mouse E-selectin (MES-1, kind gift from Dr.D.Brown,
Celltech group (Slough, UK)) and 10 mg/ml rat-anti-mouse
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VCAM-1 (Clone MK 2.7, American type Culture Collection
(Virginia, USA)) followed by a 30 min incubation with 10 mg/ml
unlabeled rabbit-anti-rat secondary antibody (Vector Laborato-
ries, Burlingame, CA, USA). After detection of peroxidase activity
with 3-amino-9-ethylcarbazole, sections were counterstained with
Mayer’s hematoxylin. Frozen sections were used for oil-red O
staining to evaluate accumulation of neutral lipids in the liver and
kidney. Images were taken with Aperio ScanScope XT (Aperio,
Vista, CA, USA) using 2006 magnification and the extent of
macrophage infiltration in the glomeruli and the diameter of
epididymal adipocytes were determined by morphometry in a
blinded manner using aperio imagescope IHC analysis algorithm
(Aperio, Vista).
Kidney Function Measured by Albumin/Creatinine Ratio
To assess renal function, the microalbumin and creatinine levels
were measured in mouse urine using commercially available kits.
Mouse Albumin ELISA Quantitation set (Bethyl laboratories,
Montgomery, Texas, USA) and creatinine clearance (Exocell,
Philadelphia, PA) according to the manufacturer’s instructions.
Statistical Analysis
Data were analyzed with Graphpad prism (Graphpad software
5.0, San Diego CA, USA) and SPSS 17.0 for Windows. Changes
over time were evaluated with two-way repeated measures
ANOVA with factors treatment (between subjects) and time
(within subjects) followed by Bonferroni, post-hoc analysis.
Differences between groups at one specific time point were
analyzed with 1-way ANOVA followed by LSD post-hoc analysis.
P,0.05 was considered significant. Results are shown as means 6
SEM, unless stated otherwise.
Figure 1. Effect of alternate high-fat dietary regimen on body weight, food intake and plasma cholesterol. (a) Food intake, (b) body
weight gain, and (c) plasma cholesterol. Groups are abbreviated as: Mice fed low- fat diet (LFD, n = 15); mice fed intermediate- fat diet (IFD, n = 15);
mice fed high- fat diet (HFD, n = 15), and mice fed 4 days LFD and 3 days HFD, alternating- fat diet (AFD, n= 15). ***p,0.001, *p,0.05 compared to
LFD, # p,0.05 compared to IFD and $ p,0.05 compared to AFD. Values are represented as means 6 SEM.
doi:10.1371/journal.pone.0045866.g001
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Results
Both Alternating and Intermediate-Fat Dietary Regimens
Reduce Body Weight Gain and Improve Plasma Lipids
The average food intake expressed as kCal/24 hours did not
differ significantly between the groups (Figure 1a). Body weight at
baseline (week 0) was 24.060.2 g on average of all groups
together. Mice that consumed a HFD displayed a gradual increase
in body weight over the 16 week diet intervention period
(19.061.0 g weight gained at week 16). Compared to HFD fed
mice, the increase in body weight during the 16 week diet period
was significantly lower at all-time points in mice that consumed a
LFD, IFD or AFD. (8.360. 7 g, 7.860.6 g and 7.260.7 g for
LFD, IFD and AFD, respectively after 16 weeks) (Figure 1b).
Total plasma cholesterol at baseline (week 0) of all groups
together was 3.9360.11 mM. Mice that consumed a HFD showed
a gradual increase in plasma cholesterol levels over time. At week
16, plasma cholesterol levels in the HFD group (8.6360.67 mM)
were significantly higher when compared to the LFD
(5.4260.29 mM), the IFD (5.3560.45 mM) or the AFD
(5.4660.27 mM) groups (Figure 1c).
Both Alternating and Intermediate-Fat Dietary Regimens
Decrease Adipocyte Size and Reduce Leptin Production
Adipocyte size in the epididymal adipose tissue in the HFD
group was significantly increased when compared to the LFD, IFD
and AFD groups (Figure 2a and 2b). At t = 0 plasma leptin levels
were 2.560.21 ng/ml on an average of all groups together. At 16
weeks, the HFD group showed a significant increase in plasma
leptin levels (76.265.9 ng/ml), when compared to the other three
Figure 2. Effect of alternate high-fat dietary regimen on adipocyte size and plasma leptin production. (a) Adipocyte morphology
(2006), (b) quantification of the adipocyte size (n = 6 animals/group) and (c) plasma leptin levels (week 16) (c). Groups are abbreviated as: Mice fed
low- fat diet (LFD); mice fed intermediate- fat diet (IFD); mice fed high- fat diet (HFD) and mice fed 4 days LFD and 3 days HFD, alternating- fat diet
(AFD). ***p,0.001. Values are represented as means 6 SEM.
doi:10.1371/journal.pone.0045866.g002
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groups (LFD 14.762.1 ng/ml, IFD 16.463.6 ng/ml and AFD
13.362.8 ng/ml) (Figure 2c).
Both Alternating and Intermediate-Fat Dietary Regimens
Reduce Fasting Blood Glucose, Plasma Insulin, and
Glucose Intolerance
To investigate whether the increase in body weight after high-
fat diet consumption was associated with systemic insulin
resistance, we determined blood glucose (n = 8/group) and plasma
insulin (n = 15/group) levels and performed oral glucose tolerance
tests (n = 8/group), two weeks before (week 22 baseline) the start
of the dietary interventions and two weeks prior to sacrifice (week
18). No significant differences in fasting blood glucose (average
8.7860.44 mM) or plasma insulin (average 0.3460.02 mM) levels
were observed at baseline between the different groups. Plasma
glucose levels after 18 weeks in the HFD group (12.7660.90 mM)
were significantly higher, when compared to the LFD
(10.1960.29 mM), IFD (7.9860.79 mM) and AFD
(8.1361.02 mM) groups (Figure 3a). Also, fasting plasma insulin
levels in the HFD group (3.0760.52 ng/ml) were significantly
higher when compared to the LFD (0.9160.12 ng/m)l, IFD
(0.9160.12 ng/ml) and AFD (0.9260.13 ng/ml) groups
(Figure 3b).
At baseline, all mice were able to clear a bolus of glucose within
120 min (Figure 3c, dotted line). However, after 18 weeks, mice on
a HFD showed glucose intolerance, whereas mice that had
consumed a LFD, IFD or AFD were still able to clear a glucose
bolus in 120 min (Figure 3c). The area under curve (AUC) of the
HFD group was significantly higher compared to the other three
groups (LFD, IFD, and AFD) (Figure 3d).
Figure 3. Effect of alternate high-fat dietary regimen on fasting plasma glucose, fasting plasma insulin, and glucose intolerance
after 18 weeks. (a) Fasting plasma glucose (n = 8 animals/group), (b) fasting plasma insulin (n = 15 animals/group), (c) glucose tolerance (n = 8
animals/group), and (d) Area under curve of the glucose tolerance test. Groups are abbreviated as: Mice fed low- fat diet (LFD); mice fed intermediate-
fat diet (IFD); mice fed high- fat diet (HFD) and mice fed 4 days LFD and 3 days HFD, alternating- fat diet (AFD)). Lines with regular ticks indicate base
line levels of the glucose clearance from blood. *p,0.05, **p,0.01, ***p,0.001. Values are represented as means 6 SEM.
doi:10.1371/journal.pone.0045866.g003
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Both Alternating and Intermediate-Fat Dietary Regimens
Reduce Lipid Accumulation and Expression of
Inflammatory Markers in the Liver
At sacrifice, livers were significantly heavier in the HFD group
(1.7560.14 g), when compared to the other three groups (LFD
1.3260.06 g, IFD 1.0860.04 g and AFD 1.1560.04 g)
(Figure 4a). Histological analyses demonstrated marked differences
in the accumulation of lipid droplets in the liver among the four
groups. In the HFD group fatty livers were observed (hepatic
steatosis) as evidenced by numerous lipid droplets in the livers of
these mice. Livers from mice of the LFD and IFD groups showed
fewer lipid droplets whereas in the AFD group only occasionally
droplets were observed in the PAS staining (Figure 4b). Consistent
with these results, livers from mice of the HFD group showed
more extensive oil-red O (ORO) staining compared to the other
three groups (Figure 4c).
To investigate the effect of the diets on hepatic inflammation
and endothelial activation, we next analyzed mRNA expression
levels of various markers (Table 1). Compared to the LFD group,
hepatic mRNA expression levels of endothelial activation markers
VCAM-1, ICAM-1, and endothelin-1 were significantly upregu-
lated in livers of the HFD group in conjunction with increased
mRNA levels of the macrophage marker CD68. Compared to
continuous HFD feeding, the AFD group showed decreased
expression levels of Endothelin-1 and CD68 whereas in the IFD
group no differences were observed in the expression of VCAM-1
and CD68 (Table 1).
Both Alternating and Intermediate- Fat Dietary Regimens
Reduce Renal Inflammation and Improve Renal Function
At sacrifice, no significant differences were found in kidney
weights between the groups (data not shown). Light microscopic
analysis revealed the development of mild renal abnormalities in
mice that had consumed a HFD chronically. This included
mesangial area expansion, thickening of Bowman’s capsule and
basement membranes, accumulation of lipid droplets in tubuli,
Figure 4. Effect of alternate high-fat dietary regimen on lipid accumulation after 20 weeks. (a) Liver weight, (b) PAS staining of the liver,
and (c) Oil Red O (ORO) staining in the liver (2006). Groups are abbreviated as: Mice fed low- fat diet (LFD); mice fed intermediate- fat diet (IFD); mice
fed high- fat diet (HFD) and mice fed 4 days LFD and 3 days HFD, alternating- fat diet (AFD). **p,0.01, ***p,0.001. Values are represented as means
6 SEM.
doi:10.1371/journal.pone.0045866.g004
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and protein cast formation (Figure 5a). Representative examples of
Oil Red O staining of renal sections demonstrating abundant
positive staining in the kidneys of HFD treated mice compared to
LFD, IFD or AFD treated mice (Figure S2). At t = 0 albumin/
creatinine levels were 2926110 mg/mg on average for all groups.
In mice fed a chronic HFD, urinary albumin/creatinine levels
gradually increased reaching statistical significance at the end of
the experimental period when compared to the other groups; at 16
weeks: 4946169 mg/mg in HFD, 3406166 mg/mg in LFD,
2756119 mg/mg in IFD and 3746178 mg/mg in AFD (Figure 5b).
Renal mRNA expression levels of various markers for endo-
thelial activation (VCAM-1, ICAM-1, and Endothelin-1), inflam-
mation (MCP-1 and CD68) and fibrosis (Desmin, and PDGF-b)
were significantly upregulated in the HFD group compared to the
LFD group. Interestingly, the AFD group had markedly decreased
expression levels of Endothelin-1, and MCP-1 when compared to
the HFD group, and decreased levels of CD68 when compared to
the HFD and IFD groups. Furthermore, we observed increased
mRNA expression levels of renal injury markers NGAL and KIM-
1 in the HFD group compared to other three groups (Figure 5c–d)
although statistical significance was only reached for NGAL when
compared to the LFD group. Consistent with the mRNA
expression levels, immunohistochemical analysis revealed in-
creased expression of VCAM-1, especially in glomeruli, in the
HFD group compared to other three groups (Figure S3a).
Immunohistochemistry of E-selectin showed restricted glomerular
expression in all four groups. However, both HFD and AFD
groups showed slightly increased expression compared to LFD and
IFD groups (Figure S3b). Increased infiltration of FA11+
macrophages was detected in the kidneys of HFD treated mice
which mainly accumulated in glomeruli as quantified by
morphometry (Figure 6b). Compared to the HFD group, mice
fed an AFD displayed substantially less glomerular macrophage
accumulation, which was comparable to the LFD and IFD groups
(Figure 6a).
Discussion
In the current study, we employed a humanized mouse model,
the ApoE*3 Leiden (E3L) male mouse, to determine whether an
alternating dietary regimen of high and low fat intake reduces
metabolic and cardiovascular risk factors as compared to a
continuous high fat diet. We showed that by adapting to a diet
with pulsed intake of high and low fat diets (4 days low-fat diet and
3 days high- fat diet in a week) instead of a continuous high- fat
diet, fasting plasma glucose and insulin levels were reduced and
insulin sensitivity is improved. Furthermore, the alternating high-
fat dietary regimen replicated most of the beneficial effects
instigated by daily consumption of a low- fat or intermediate- fat
diet including reduced body weight gain and plasma cholesterol
levels, improved adipocyte physiology, reduced hepatic and renal
inflammation and improved renal function compared to contin-
uous HFD.
Recently, we reported the beneficial effects of a similar dietary
strategy with high cholesterol containing diets (alternating high-
cholesterol dietary regimen) on the occurrence of atherosclerosis,
hepatic and renal activation and inflammation [8]. This study
together with the results presented here and existing literature
[7,8] indicate that the principle of an alternating dietary regimen
(ADR) is a strong alternative for some of the inflexible daily calorie
restriction strategies available so far.
The exact molecular mechanisms underlying the beneficial
effects of the alternating dietary strategy are not yet fully
understood. Based on literature and our own findings we speculate
that chronic and/or long term exposure to excessive or
inappropriate nutrients places a heavy burden on adaptive
responses that leads to a gradual loss of metabolic homeostasis
and a pattern of continuous, low-grade inflammatory and stress
responses, leading ultimately to metabolically driven pathologies
[11,12]. Recently, we showed that feeding E3L male mice a high-
fat diet chronically results in increased body weight and plasma
lipid content and induces insulin resistance in liver and adipose
tissue [9]. In addition, we showed that a high- fat diet leads to
hepatic steatosis and changes in adipose tissue physiology [9]. In
the current study, we found that an alternating high- fat dietary
regimen, similar to low- fat and intermediate- fat diets, signifi-
cantly diminished these metabolic and functional risk factors as
reflected by reduced body weight gain, reduced total plasma
cholesterol levels and reduced adipocyte size and leptin produc-
tion.
In the liver, accumulation of lipids, as observed in mice fed a
HFD chronically, is a major cause of oxidative stress and
inflammation causing the liver to gain size and weight and
inducing hepatic steatosis [3]. Here, we found that mice exposed
to an alternating high- fat dietary regimen were protected against
the increase in liver weight and the development of hepatic
steatosis when compared to daily HFD feeding. Also, AFD fed
mice displayed diminished liver inflammation as evidenced by
significantly reduced mRNA expression levels of various inflam-
matory markers although most of these markers were still elevated
when compared to the LFD group.
The development of type 2 diabetes is well known to be
associated with renal structural and functional changes character-
Table 1. Relative mRNA expression levels of proinflammatory
genes.
Hepatic gene expression profiling
LFD (n=14) HFD (n=14) IFD (n =14) AFD (n=13)
VCAM-1 1.0060.48 a 2.0660.85 b 1.5061.20 ab 1.6160.55 ab
ICAM-1 1.0060.44 a 1.8460.62 b 1.2860.86 ac 1.5060.32 bc
Endothelin-1 1.0060.50 a 1.5560.49 b 1.2960.73 ab 1.1060.53 a
CD68 1.0060.52 a 1.3560.39 b 1.0360.53 ab 0.9160.22 a
Renal gene expression profiling
LFD (n=14) HFD (n=14) IFD (n =14) AFD (n=13)
VCAM-1 1.0060.24 a 1.6060.88 b 1.3460.58 ab 1.4360.31 ab
ICAM-1 1.0060.27 a 1.4660.33 b 1.4560.58 ab 1.6960.53 b
E-selectin 1.0060.51 a 1.4860.58 ab 1.6161.06 ab 2.5661.75 b
Endothelin-1 1.0060.26 a 1.9161.01 b 0.8260.43 a 1.1760.28 a
CD68 1.0060.34 a 1.4660.76 b 1.3460.54 ab 0.8460.25 ac
MCP-1 1.0060.57 a 2.2562.12 b 1.0760.57 a 1.2460.56 a
PDGF-b 1.0060.20 a 1.4360.48 b 1.1160.30 a 1.3160.22 ab
Desmin 1.0060.22 a 1.4560.47 b 1.1060.42 a 1.2260.31 a
Hepatic mRNA expression of endothelial activation (VCAM-1, ICAM-1 and
endothelin-1) and inflammation markers (CD68). Renal mRNA expression of
endothelial activation (VCAM-1, ICAM-1, E-selectin and Endothelin-1),
inflammation (MCP-1 and CD68), and fibrosis markers (Desmin and PDGF-b).
Groups are abbreviated as: Mice fed low- fat diet (LFD); mice fed intermediate-
fat diet (IFD); mice fed high- fat diet (HFD) and mice fed 4 days LFD and 3 days
HFD, alternating- fat diet (AFD). Superscripts without a common letter differ
significantly P,0.05. Values are represented as means 6 SD.
doi:10.1371/journal.pone.0045866.t001
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ized by renal inflammation and glomerulosclerosis, decline in
glomerular filtration rate and the occurrence of proteinuria
[13,14]. Similar to the liver, intrarenal accumulation of lipids
has been proposed to play a major role in causing diabetes
associated nephropathy [10]. For example, intrarenal lipid
accumulation induces glomerular expression of MCP-1 and
VCAM-1 [15,16], which contribute to glomerular macrophage
accumulation [8,17], eventually leading to albuminuria [18]. In
the current study, several parameters analyzed were consistent
with the development of (early) diabetic nephropathy in HFD fed
mice including the development of albuminuria and histological
evidence for mesangial area expansion, thickening of Bowman’s
capsule and tubular basement membranes [19,20], tubular lipid
accumulation and protein cast formation. These renal structural
and functional changes were associated with increased mRNA
expression levels of markers for endothelial activation (VCAM-1,
ICAM-1, E-selectin and endothelin-1), inflammation (MCP-1 and
macrophage marker CD68), fibrosis (desmin and PDGF-b) [13,19]
and renal injury markers (NGAL and KIM-1) [21], in the HFD
group compared to the LFD group. Recently, Fu WJ et al.,
reported an association between glomerular hyperfiltration,
elevated tubular injury markers and decline in kidney function
in diabetic nephropathy patients [21]. Interestingly, mice subject-
ed to the AFD regimen displayed downregulated expression levels
of the endothelial dysfunction marker endothelin-1, the inflam-
matory markers MCP-1 and CD68 and the fibrosis markers
desmin when compared to HFD fed mice.
In our experiments, a group of mice (IFD group) was included
that received a 25% (energy) fat diet daily to compare with the
overall dietary fat intake of mice exposed to the AFD regimen (4
days 10%, 3 days 45%). For many of the parameters analyzed, the
beneficial effects detected in the AFD group were also observed in
Figure 5. Effect of alternate high-fat dietary regimen on renal morphology and function. (a) Morphology of the kidney (PAS staining).
Mesangial expansion (PAS positive area) (red arrow), thickening of the Bowman ’s capsule (yellow arrow), thickening of tubular basement membrane
(blue arrow), vacuolarization (lipid accumulation) of the tubules (green arrow), and protein cast formation (orange arrow) (inset- highlighted areas in
HFD kidney) (2006) (b) Albumin: creatinine ratio (n = 13215). Lines with regular ticks indicate base line levels. (c) relative mRNA expression levels of
NGAL, (d) relative mRNA expression levels of KIM-1. Groups are abbreviated as: Mice fed low- fat diet (LFD); mice fed intermediate- fat diet (IFD); mice
fed high- fat diet (HFD) and mice fed 4 days LFD and 3 days HFD, alternating- fat diet (AFD). *p,0.05, **p,0.01. Values represented as individual
animal + mean.
doi:10.1371/journal.pone.0045866.g005
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the IFD group with only minor differences in some parameters
(e.g., CD68 mRNA expression in the liver). These data are in line
with recent studies by de Wit et al. who demonstrated that
increasing the dietary fat (palm oil) content from 10 kcal% to
20 kcal% did not significantly increase body weight gain in
C57Bl6 mice. These findings and the data presented here suggest
that the metabolic system is able to successfully cope with a certain
amount of dietary fat (buffering capacity) without considerably
affecting metabolic homeostasis and triggering inflammatory
responses [22]. Overall, these results indicate that a threshold
exists for metabolic overload, beyond which the body cannot cope
with metabolic stress leading to the induction of various
abnormalities. Our current study indicates that the threshold
under our experimental conditions must be in between the 25 and
45% lard fat diet. Thus, reduction in metabolic stress caused by a
high fat diet can be achieved either by giving the body time to
recover from the metabolic overload caused by high fat
(alternating- fat diet strategy) or by lowering the daily fat intake
(Intermediate- fat diet strategy).
In conclusion, this study indicates that the beneficial effects of
alternating feeding regimens on metabolic and functional risk
factors for CVD are not only applicable for cholesterol containing
diets, as we have shown previously, but can be extended to high-
fat containing diets. These results provide further support for the
concept of alternating dietary regimens as a means to protect
against the adverse effects of an unhealthy diet. Additional studies
are needed to examine whether the principles of alternating and
intermediate dietary regimens can also be implemented to
improve existing metabolic diseases. For example, it would be
interesting to investigate whether an alternating or intermediate
diet can attenuate or reverse the negative effects caused by a long-
term HFD consumption in terms of body weight, glucose tolerance
and hepatic steatosis. Finally, the ultimate goal is to examine
whether the concept of alternating feeding regimens can be
translated to humans.
Supporting Information
Figure S1 Schematic representation of the feeding
regimens. Illustration of blood and urine collection. The red
droplets indicate blood sampling time points, green droplets
indicate urine collection time points and blue drop lets indicate
blood sampling at the time of oral glucose tolerance test. Groups
are abbreviated as: Mice fed low- fat diet (LFD); mice fed
intermediate- fat diet (IFD); mice fed high- fat diet (HFD), and
mice fed 4 days LFD and 3 days HFD, alternating- fat diet (AFD).
(TIF)
Figure S2 Effect of alternating high- fat dietary regimen
on renal neutral lipid accumulation. Oil Red O (ORO)
staining in the kidney (2006). Groups are abbreviated as: Mice fed
low- fat diet (LFD); mice fed intermediate- fat diet (IFD); mice fed
high- fat diet (HFD) and mice fed 4 days LFD and 3 days HFD,
alternate- fat diet (AFD).
(TIF)
Figure S3 Effect of alternate high- fat dietary regimen
on expression of endothelial adhesion molecules in
kidney. (a) Expression and localization of VCAM-1 and (b) E-
selectin (2006). Inset shows a 2006 magnification of a
representative glomerulus which is indicated by the arrow. Groups
are abbreviated as: Mice fed low- fat diet (LFD); mice fed
intermediate- fat diet (IFD); mice fed high- fat diet (HFD) and
mice fed 4 days LFD and 3 days HFD, alternate- fat diet (AFD).
(TIF)
Table S1 Composition of the different diets used in this
study. Rodent diets with 10, 25, or 45 kcal% Fat (from Mostly
Lard) and with 213 mg Cholesterol/kg Diet.
(DOCX)
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Figure 6. Effect of alternate high-fat dietary regimen on renal inflammation. (a) Immunohistochemistry of macrophage infiltrates. Inset
shows a representative glomerulus which is indicated by arrow mark (2006), and (b) quantification of macrophage infiltrates in glomeruli (n = 8
animals/group). Groups are abbreviated as: Mice fed low- fat diet (LFD); mice fed intermediate- fat diet (IFD); mice fed high- fat diet (HFD) and mice
fed 4 days LFD and 3 days HFD, alternating- fat diet (AFD). *p,0.05, **p,0.01. Values are represented as means 6 SEM.
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